• Skip to main content
  • Es
  • En
Linkedin
  • Services
    By Phases
    Preclinical and R&D
    Biomarkers Analysis
    Inmmunogenicity Assay
    Metabolomics
    Nucleic Acid Bioanalysis & Gene Therapy
    Pharmacokinetic Analysis (PK/PD)
    Regulated Impurities
    Analytical Method Development, Validation & Transfer
    Oligonucleotides
    Peptide And Amino Acid Analysis
    Protein And Biologics Characterization
    Protein Analysis
    CMC And QC
    Biosimilar Analysis
    Microbiology Control
    QC Testing
    Vaccine Analysis
    Metabolomics
    Nucleic Acid Bioanalysis & Gene Therapy
    Oligonucleotides
    Peptide And Amino Acid Analysis
    Protein Analysis
    Regulated Impurities
    Analytical Method Development, Validation & Transfer
    By Molecules
    Small Molecules
    TIDES
    Biologics
    Advanced Therapies
  • About Us
    AMSbiopharma
    Innovation
    Quality
    Careers
  • News
  • Contact
  • Services
    By Phases
    Preclinical and R&D
    Biomarkers Analysis
    Inmmunogenicity Assay
    Metabolomics
    Nucleic Acid Bioanalysis & Gene Therapy
    Pharmacokinetic Analysis (PK/PD)
    Regulated Impurities
    Analytical Method Development, Validation & Transfer
    Oligonucleotides
    Peptide And Amino Acid Analysis
    Protein And Biologics Characterization
    Protein Analysis
    CMC And QC
    Biosimilar Analysis
    Microbiology Control
    QC Testing
    Vaccine Analysis
    Metabolomics
    Nucleic Acid Bioanalysis & Gene Therapy
    Oligonucleotides
    Peptide And Amino Acid Analysis
    Protein Analysis
    Regulated Impurities
    Analytical Method Development, Validation & Transfer
    By Molecules
    Small Molecules
    TIDES
    Biologics
    Advanced Therapies
  • About Us
    AMSbiopharma
    Innovation
    Quality
    Careers
  • News
  • Contact

New update for the ICH Q2 (R2) guidance on Analytical Process Validation

Posted on: 05/07/2024 Last updated on: 30/09/2025 Written by: amsbiowp
As planned for months, the draft ICH Q14 Guideline for AQbD Method Development and the draft ICH Q2 (R2) Guideline for Analytical Process Validation were published at the end of 2023. Both were developed over the past year and come…
Continue reading “New update for the ICH Q2 (R2) guidance on Analytical Process Validation”…

Contact us

Let´s talk about your project 

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Subscribe to our newsletter

Stay informed with the latest news, updates, exclusive content, insightful articles, and important event announcements.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • R&D and Preclinical
    • Bioanalysis and biomarkers​
    • Metabolomics
  • Quality Control
    • Regulated Impurities / GMP
    • Analytical Method Development / GMP
    • Peptide and Amino Acid Analysis / Non-GLP
    • Oligonucleotides / Non-GLP
    • ICP-MS Analysis
    • Quality Control (QC) Testing / GMP
    • Microbiology
    • Medical cannabis
  • About us
    • AMSbiopharma
    • Innovation
    • Careers
  • News
  • Contact us
  • R&D and Preclinical
    • Bioanalysis and biomarkers​
    • Metabolomics
  • Quality Control
    • Regulated Impurities / GMP
    • Analytical Method Development / GMP
    • Peptide and Amino Acid Analysis / Non-GLP
    • Oligonucleotides / Non-GLP
    • ICP-MS Analysis
    • Quality Control (QC) Testing / GMP
    • Microbiology
    • Medical cannabis
  • About us
    • AMSbiopharma
    • Innovation
    • Careers
  • News
  • Contact us
  • Cookies Policy
  • Privacy Policy
  • Legal Notice
  • Cookies Policy
  • Privacy Policy
  • Legal Notice
Linkedin

AMSbiopharma a company of AMSlab – All rights reserved © 2024 | Made with love by ingenyus*